Objectives Over the past decade, the biological and clinical characteristics of lung cancer
with epidermal growth factor receptor (EGFR) mutation have been well studied. However …

Background To elucidate the clinical, pathologic, and prognostic impacts of epidermal
growth factor receptor (EGFR) mutation and mutation subtypes in early-stage lung cancer …

Background The presence of epidermal growth factor receptor (EGFR) mutations is an
established prognostic factor for patients with advanced lung adenocarcinoma. Here, we …

Objective Epidermal growth factor receptor (EGFR) gene mutation status is a well-
established predictor of the efficacy of EGFR tyrosine-kinase inhibitor (TKI) therapy in …

Aim With the advent of the molecular‐targeted therapy, rapid progress has been made in the
treatment of advanced or recurrent non‐small‐cell lung cancer (NSCLC). Although surgical …

Aim: The purpose of this study was to investigate the prognostic significance of epidermal
growth factor receptor (EGFR) sensitizing mutations in patients with lung adenocarcinoma …

Somatic mutations in epidermal growth factor receptor (EGFR) tyrosine kinase domain,
particularly deletions in exon 19 and point mutation in exon 21, are associated with clinical …

Background Mutation of the EGFR gene is known as a predictor for the response to EGFR
tyrosine kinase inhibitor. Although EGFR mutation status is proposed to be incorporated in …

Purpose The purpose of this study was to investigate the relationship between epidermal
growth factor receptor (EGFR) gene mutation and clinicopathological features of lung …

The purpose of this study was to evaluate the association between epidermal growth factor
receptor (EGFR) mutations and prognosis in patients with completely resected lung …